Chinese Journal of Dermatology ›› 2016, Vol. 49 ›› Issue (4): 276-278.

Previous Articles     Next Articles

Expressions of STAT3 and phosphorylated STAT3 in cutaneous malignant melanoma lesions

  

  • Received:2015-07-02 Revised:2015-11-18 Online:2016-04-15 Published:2016-03-28
  • Contact: RAN Li-wei E-mail:WLBRLW@163.com

Abstract:

Ran Liwei, Liu Hongmei, Lan Dong Department of Dermatology, Beijing Chaoyang Hospital Jingxi Campus, Capital Medical University, Beijing 100043, China (Ran LW, Lan D); Huangsi Clinic, Headquarters of General Armament Department of PLA, Beijing 100120, China (Liu HM) Corresponding author: Ran Liwei, Email: wlbrlw@163.com 【Abstract】 Objective To investigate s of STAT3 and phosphorylated STAT3 (p-STAT3) in cutaneous malignant melanoma (CMM) lesions, and to explore their significance. Methods The s of STAT3 and p-STAT3 were detected with an immunohistochemical method using polymer enzyme-labeled secondary antibodies in skin specimens from 22 CMM lesions and 23 pigmented nevus lesions. The effects of STAT3 and p-STAT3 s on lymph node metastasis of CMM were evaluated. Results The rate of STAT3 was significantly higher in CMM lesions than in pigmented nevus lesions (95.5% vs. 56.5%, χ2 = 9.23, P < 0.05), so was that of p-STAT3 (90.9% vs. 43.5%, χ2 =11.38, P < 0.05). STAT3 in CMM lesions had no obvious effects on lymph node metastasis of CMM (P > 0.05), while the elevated of p-STAT3 in CMM lesions was a predictive factor for lymph node metastasis in CMM (OR = 1.88, 95% CI: 1.05 - 3.38, P < 0.05). Conclusion Increased of STAT3 and p-STAT3 in CMM may play important roles in the pathogenesis of CMM, and elevated p-STAT3 may contribute to invasion and metastasis of CMM.